News | May 10, 2023
Boehringer Ingelheim begins clinical development for fibrotic diseases
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
The award recognizes and supports promising female scientists working in mass spectrometry
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Subscribe To Our Newsletter & Stay Updated
